The fair value and amortized cost of available-for-sale marketable securities by major security type are presented in the following tables as of the periods presented:


	March 31, 2026
Type of security	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
U.S. treasury securities	$	61,547	$	12	$	(104	)	$	61,455
Corporate bonds		40,276		1		(75	)		40,202
Commercial paper		32,880		—		(23	)		32,857
Asset backed securities		13,541		6		(6	)		13,541
U.S. government agency securities		4,317		1		(2	)		4,316
Total marketable securities	$	152,561	$	20	$	(210	)	$	152,371


	December 31, 2025
Type of Security	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
U.S. treasury securities	$	62,572	$	100	$	—		$	62,672
Commercial paper		46,773		14		(4	)		46,783
Corporate bonds		41,991		17		(3	)		42,005
Asset backed securities		13,558		17		—			13,575
U.S. government agency securities		4,304		7		—			4,311
Total marketable securities	$	169,198	$	155	$	(7	)	$	169,346

The net amortized cost and fair value of available-for-sale marketable securities are presented in the following table as of the periods presented by contractual maturity. Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company may intend to sell a security prior to maturity.


	March 31, 2026
	Amortized Cost		Fair Value
Due to mature:
Less than one year	$	102,445	$	102,386
One year through three years		50,116		49,985
Total	$	152,561	$	152,371


	December 31, 2025
	Amortized Cost		Fair Value
Due to mature:
Less than one year	$	110,769	$	110,863
One year through three years		58,429		58,483
Total	$	169,198	$	169,346

During the three months ended March 31, 2026 and 2025, there were no realized gains or losses on available-for-sale marketable securities.

As of March 31, 2026 and December 31, 2025, no marketable securities had been in a continuous unrealized loss position for more than 12 months and the Company considered any such losses to be temporary in nature. The Company reviewed the securities in the tables above and considered the decline in market value for these securities to be primarily attributable to economic and market conditions. As of the periods noted in the tables above, the Company did not intend to sell these securities and did not believe it was more likely than not that it would be required to sell these securities before recovery of their amortized cost basis. Additionally, the Company did not recognize any credit losses related to its marketable securities in an unrealized loss position during any of the periods noted in the table above.

As of March 31, 2026 and December 31, 2025, accrued interest receivables on the Company’s available-for-sale marketable securities were $1.1 million and $1.0 million, respectively, and were included within other current assets as presented on its Condensed Consolidated Balance Sheets.